The Patient Perspective: Jane’s Story
March 20, 2026
When Jane received a letter about her liver health, she admits she was surprised – but pleasantly so. Living in rural Somerset and working 30
When Jane received a letter about her liver health, she admits she was surprised – but pleasantly so. Living in rural Somerset and working 30
When the letter from the NHS dropped through my door, I’ll be honest – I didn’t panic. These days, my wife and I joke that
Somerset, UK, 18th March 2026: Predictive Health Intelligence (PHI) and Sano Genetics today announced the completion of recruitment into the LiveWell study, with 996 participants
What is case finding? Case-finding is a data-driven approach to identifying individuals within a population who may be at high risk for developing a certain
Every new therapy relies on years of painstaking research, but what if that research overlooks the very people most in need? The problem: a mismatch
Care gaps are present across the care pathway for A1ATD-related liver disease; it is significantly underdiagnosed, suffers from a lack of awareness, and currently there
Liver disease is one of the most pressing, yet under-recognised, health challenges of our time. In the UK alone, liver disease is now the third
Metabolic dysfunction-associated steatotic liver disease should not be thought of as a niche hepatology problem. It is increasingly encountered across primary care, diabetes services, cardiology,
(London, UK) 10 September 2024. Following our recent announcement that hepatoSIGHT has received MHRA UKCA marking, we are excited to share that hepatoSIGHT has now also
(London, UK) 20 August 2024. Predictive Health Intelligence’s flagship product, hepatoSIGHT, a case-finding search engine that enables clinicians to identify people potentially at risk for